| Revenue growth | 8% YoY growth in FY26. |
|---|---|
| Margins | EBITDA margin expanded from 13.3% (FY25) to 16.6% (FY26). |
| Demand visibility | Strong pipeline with 4 new API launches per year. |
| Management confidence | High; citing improved plant utilization and yields. |
Growth
FY26 Revenue grew 8% to ₹650 Cr; EBITDA rose 35% to ₹108 Cr; PAT jumped 117% to ₹66 Cr.
Outlook
Launching 4 new molecules annually from FY27; targeting formulation scale-up and further debt refinancing.
Risks
Q4 revenue declined due to the West Asia crisis impacting API export dispatches in March.
Earnings Call filed with NSE, NSE: WANBURY. Summary written with AI assistance from the document.
Wanbury Ltd: key numbers
- Share price
- ₹224.15
- Market cap
- ₹783.8 Cr
- Revenue (annual)
- ₹650.3 Cr
- Net profit (annual)
- ₹66.13 Cr
- P/E (TTM)
- 14.0×Sector 50.4×
- Promoter holding
- 43.02%+0.00% QoQ
- FII holding
- 0.89%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wanbury Ltd
All →Wanbury Management Change
Wanbury Limited announced the appointment of ABK & Associates as Cost Auditor and the re-appointment of Mohan Kumar Rayana as Executive Director.
Wanbury Annual General Meeting
Wanbury Limited held its 38th Annual General Meeting on September 24, 2026. Shareholders approved financial statements, director re-appointments, and cost auditor remuneration ratification.
Wanbury Q1 FY27 Results: Net Profit ₹3.2 Cr, Down 76.3% YoY
Wanbury Ltd reported revenue from operations of ₹165.6 Cr (+1.5% YoY) and net profit of ₹3.2 Cr (-76.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹3.2 Cr · -76.3% YoY
Wanbury Q4 FY26 Results: Net Profit ₹21.7 Cr, Up 6.9% YoY
Wanbury Ltd reported revenue from operations of ₹164.6 Cr (-4.3% YoY) and net profit of ₹21.7 Cr (+6.9% YoY) for Q4 FY26.
- Key figure
- Net profit ₹21.7 Cr · +6.9% YoY